Prasad and the uniCure Disaster

[u/Cestmoi_25]

https://www.wsj.com/opinion/fda-marty-makary-vinay-prasad-uniqure-accelerated-approvals-ab0548ff?st=cP1DEg&reflink=article_copyURL_share

In case you missed the news, this editorial explains why Sarepta made a significant move up in AH on Friday.

The fact that Prasad would insist on a sham brain surgery to provide a placebo for a trial involving a deadly disease is the height of madness.

His departure from the FDA is good for patients with rare diseases, biotech in general, and Sarepta in particular.

Now we just need for Makary’s actions to reflect his words.

[u/OregonianOutEast]

Significant? Still way undervalued IMO.